ReHeva Biosciences - Conquering Columbus Podcast - Episode 310

ReHeva BioSciences

Dr. Zeenia Kaul, CEO and CSO at ReHeva Biosciences. ReHeva Biosciences, a clinical-stage biopharmaceutical startup founded in 2016, is discovering and developing naturally occurring, complex botanical agents to treat and manage cancer. Their goal is to help people live longer and healthier with cancer, ultimately transforming cancer treatment into disease management. They recently started their first Phase I Clinical trial of their drug, RH324.

Listen Now!

Newest posts

Sign up for free
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Sign up right away

Sign up now and get the best insurance on the market

“Using this template has saved my marriage! I am more than thrilled!”

Gianna Johnson
Director @Company